Find out about Anvisa's priorities for the next biennium
RDC 753 - New Regulatory Framework for the Registration of Synthetic Drugs.
What are the challenges in ensuring access to high-cost medicines?
WHAT ARE THE STEPS FOR OBTAINING AUTHORIZATION FOR CLINICAL STUDIES IN BRAZIL?
Important circumstances for the submission of drug registration in Brazil
What are the topics of interest and ANVISA’s availability for meetings?
What is the purpose of registration submission guide, based on data from scientific literature?
Six suggestions for a successful Advisory Board
Biological and biosimilar medicines - development and commercialization challenges
What is required to file a drug patent application?
What are the main differences between the ICH guides and the ANVISA requirements?
Drug stability studies. Why are they important?
The innovation that comes from the University
What was the impact of the pandemic on clinical studies?
Access to post-study medicines: status in Brazil and challenges yet to be overcome.
Pharmaceutical Industry – focused on the future
Descentralized clinical studies
The economic impact of the new health technologies
ANVISA – Post-pandemic challenges and perspectives.